Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Primary immunodeficiencies. II. Current therapeutic possibilities]

J Litzman1

  • 1Ustav klinické imunologie LF MU, FN u sv. Anny, Brno.

Casopis Lekaru Ceskych
|September 11, 1996
PubMed
Summary

Treatment options for primary immunodeficiencies are limited, with bone marrow and gene transplantation being intensive options. Immunoglobulin replacement and antibiotic prophylaxis are key management strategies for these immune system disorders.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Possibilities for the analysis of peripheral blood B cell subpopulations in a routine immunological laboratory.

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2022
Same author

[Recurrent meningitis and inherited complement deficiency].

Epidemiologie, mikrobiologie, imunologie : casopis Spolecnosti pro epidemiologii a mikrobiologii Ceske lekarske spolecnosti J.E. Purkyne·2017
Same author

When to initiate immunoglobulin replacement therapy (IGRT) in antibody deficiency: a practical approach.

Clinical and experimental immunology·2016
Same author

Hereditary angio-oedema with C1 inhibitor deficiency: Characteristics and diagnostic delay of Czech patients from one centre.

Allergologia et immunopathologia·2016
Same author

Spectrum and management of complement immunodeficiencies (excluding hereditary angioedema) across Europe.

Journal of clinical immunology·2015
Same author

Influence of FCRN expression on lung decline and intravenous immunoglobulin catabolism in common variable immunodeficiency patients.

Clinical and experimental immunology·2014

Area of Science:

  • Immunology
  • Genetics
  • Infectious Diseases

Context:

  • Primary immunodeficiencies (PIDs) present limited treatment avenues.
  • Current causal therapies like bone marrow transplantation are reserved for severe cases.
  • Gene therapy for PIDs is experimental with limited clinical experience.

Purpose:

  • To review current and potential therapeutic strategies for primary immunodeficiencies.
  • To highlight the role of supportive care in managing PIDs.

Summary:

  • Treatment for PIDs is challenging, with few curative options available.
  • Immunoglobulin replacement therapy is a common supportive measure.
  • Antibiotic, antiviral, and antifungal prophylaxis are crucial for preventing infections in PID patients.

Related Experiment Videos

Impact:

  • Improved understanding of PID management strategies.
  • Guidance on the appropriate use of immunoglobulin and antimicrobial prophylaxis.
  • Highlights the need for further research in gene therapy for PIDs.